» Articles » PMID: 22573178

RI-1: a Chemical Inhibitor of RAD51 That Disrupts Homologous Recombination in Human Cells

Overview
Specialty Biochemistry
Date 2012 May 11
PMID 22573178
Citations 102
Authors
Affiliations
Soon will be listed here.
Abstract

Homologous recombination serves multiple roles in DNA repair that are essential for maintaining genomic stability. We here describe RI-1, a small molecule that inhibits the central recombination protein RAD51. RI-1 specifically reduces gene conversion in human cells while stimulating single strand annealing. RI-1 binds covalently to the surface of RAD51 protein at cysteine 319 that likely destabilizes an interface used by RAD51 monomers to oligomerize into filaments on DNA. Correspondingly, the molecule inhibits the formation of subnuclear RAD51 foci in cells following DNA damage, while leaving replication protein A focus formation unaffected. Finally, it potentiates the lethal effects of a DNA cross-linking drug in human cells. Given that this inhibitory activity is seen in multiple human tumor cell lines, RI-1 holds promise as an oncologic drug. Furthermore, RI-1 represents a unique tool to dissect the network of reaction pathways that contribute to DNA repair in cells.

Citing Articles

Amodiaquine ameliorates stress-induced premature cellular senescence via promoting SIRT1-mediated HR repair.

Du J, Chen F, Du C, Zhao W, Chen Z, Ding Z Cell Death Discov. 2024; 10(1):434.

PMID: 39394181 PMC: 11470136. DOI: 10.1038/s41420-024-02201-1.


DNA damage response in breast cancer and its significant role in guiding novel precise therapies.

Li J, Jia Z, Dong L, Cao H, Huang Y, Xu H Biomark Res. 2024; 12(1):111.

PMID: 39334297 PMC: 11437670. DOI: 10.1186/s40364-024-00653-2.


RAD51 regulates eukaryotic chromatin motions in the absence of DNA damage.

Maarouf A, Iqbal F, Sanaullah S, Locatelli M, Atanasiu A, Kolbin D Mol Biol Cell. 2024; 35(11):ar136.

PMID: 39292916 PMC: 11617103. DOI: 10.1091/mbc.E24-04-0188.


Changes in repair pathways of radiation-induced DNA double-strand breaks at the midblastula transition in Xenopus embryo.

Morozumi R, Shimizu N, Tamura K, Nakamura M, Suzuki A, Ishiniwa H J Radiat Res. 2024; 65(3):315-322.

PMID: 38648785 PMC: 11115444. DOI: 10.1093/jrr/rrae012.


RNF4 sustains Myc-driven tumorigenesis by facilitating DNA replication.

Her J, Zheng H, Bunting S J Clin Invest. 2024; 134(10).

PMID: 38530355 PMC: 11093604. DOI: 10.1172/JCI167419.


References
1.
Connell P, Siddiqui N, Hoffman S, Kuang A, Khatipov E, Weichselbaum R . A hot spot for RAD51C interactions revealed by a peptide that sensitizes cells to cisplatin. Cancer Res. 2004; 64(9):3002-5. DOI: 10.1158/0008-5472.can-03-3608. View

2.
Dupre A, Boyer-Chatenet L, Sattler R, Modi A, Lee J, Nicolette M . A forward chemical genetic screen reveals an inhibitor of the Mre11-Rad50-Nbs1 complex. Nat Chem Biol. 2008; 4(2):119-25. PMC: 3065498. DOI: 10.1038/nchembio.63. View

3.
Bello V, Aloyz R, Christodoulopoulos G, Panasci L . Homologous recombinational repair vis-à-vis chlorambucil resistance in chronic lymphocytic leukemia. Biochem Pharmacol. 2002; 63(9):1585-8. DOI: 10.1016/s0006-2952(02)00954-1. View

4.
Paques F, Haber J . Multiple pathways of recombination induced by double-strand breaks in Saccharomyces cerevisiae. Microbiol Mol Biol Rev. 1999; 63(2):349-404. PMC: 98970. DOI: 10.1128/MMBR.63.2.349-404.1999. View

5.
Mitra A, Jameson C, Barbachano Y, Sanchez L, Kote-Jarai Z, Peock S . Overexpression of RAD51 occurs in aggressive prostatic cancer. Histopathology. 2009; 55(6):696-704. PMC: 2856636. DOI: 10.1111/j.1365-2559.2009.03448.x. View